Introduction
Synapsin III (Syn III) is a synaptic phosphoprotein negatively regulating striatal dopamine (DA) release by cooperating with α-synuclein (α-syn) (Hosaka and Sudhof, 1998; Kile et al., 2010; Zaltieri et al., 2015) . We recently described that in Parkinson's disease (PD), the most common neurodegenerative movement disorder, characterized by progressive loss of dopaminergic neurons of the substantia nigra, Syn III associates with α-syn to compose the insoluble fibrils forming Lewy Bodies (LB) (Longhena et al., 2018; Spillantini et al., 1997) . Aggregation and deposition of α-syn at synaptic sites are considered as the primum movens for the derangement of dopaminergic neurons in PD (Bellucci et al., 2016) . Our recent findings support that, besides composing α-syn insoluble fibrils, Syn III acts as a crucial mediator of α-syn aggregation and toxicity. Indeed, Syn III knock out (ko) mice do not develop α-syn insoluble aggregates and the related degeneration of dopaminergic nigrostriatal neurons prompted by the adeno-associated virus (AAV)-induced overexpression of human wild type (wt) α-syn (Faustini et al., 2018) .
Syn III regulates DA release and is the only synapsin co-localizing with vesicular monoamine transporter 2 (VMAT2) in the striatum (Bogen et al., 2006; Faustini et al., 2018) . Our previous studies indicating that Syn III is up-regulated in the absence of α-syn in mesencephalic dopaminergic neurons subjected to α-syn gene silencing, or produced from α-syn null mice (C57BL/6JOlaHsd), support the existence of a crucial interplay between Syn III and α-syn (Zaltieri et al., 2015) . The compensatory increase of Syn III observed in mice lacking α-syn mediates a paradoxical over-response to the administration of the monoamine reuptake inhibitor (MRI) cocaine, which can stimulate synapsin-dependent DA release (Venton et al., 2006) . Contrariwise, α-syn null background, show a marked co-accumulation of α-syn and Syn III in the striatum (Zaltieri et al., 2015) , similarly to PD patients (Longhena et al., 2018) . These mice progressively develop α-syn insoluble aggregates in dopaminergic nigrostriatal neurons from 2 months of age. At 12 months of age, they exhibit reduced basal and K + -stimulated striatal DA release associated with redistribution of soluble NSF attachment protein receptor (SNARE) proteins and DAT, without a frank dopaminergic cell loss (Bellucci et al., 2011; Garcia-Reitbock et al., 2010; Tofaris et al., 2006) . Amphetamine-induced motor abnormalities are also detected at 18 months of age (Tofaris et al., 2006) . Thus, this transgenic mouse line constitutes a progressive model of PD, recapitulating the earliest α-syn-related synaptic derangement of dopaminergic neurons that may initiate neuronal loss (Garcia-Reitbock et al., 2010) . This is in line with evidence supporting the relevance of truncated αsyn in the early pathogenic steps leading to LB formation (Prasad et al., 2012) . Indeed, the core of LB is enriched in C-terminally truncated α-syn (Prasad et al., 2012) , which assembles into filaments and forms inclusions much more readily than full length (fl), wt or mutated protein (Crowther et al., 1998; Fares et al., 2016) .
Methylphenidate (MPH), a MRI currently used for the treatment of attention deficits and hyperactivity disorder (ADHD) (Huss et al., 2017) , that can be associated with Syn III or α-syn polymorphisms (Basay et al., 2016; Gerlach et al., 2019; Kenar et al., 2013) , has been found to efficiently counteract freezing of gait in advanced PD (Delval et al., 2015; Devos et al., 2007; Moreau et al., 2012; Nikolai Gil D. Reyes, 2018; Pollak et al., 2007) . Notably, MPH displays α-syn binding ability and results able to stimulate α-syn-mediated DA neurotransmission (Chadchankar et al., 2012; Kile et al., 2010; Venton et al., 2006) , supporting that α-syn/Syn III interplay may influence the effect of this drug. The aim of this study was to assess whether and how the formation washes in 0.3% Triton X-100 PBS, slices were incubated for 2 h at rt with the second primary antibody prepared in blocking solution, followed by incubation for 1 h at rt with the optimal fluorochrome-conjugated secondary antibody. The sections undergoing triple immunolabeling were further subjected to incubation with a third primary antibody for 2 h at rt followed by incubation for 1 h with the fluorochrome-conjugated secondary antibody. Finally, cell nuclei were counterstained with TO-PRO ® -3 Iodide (To Pro, Thermo Fisher Scientific, Waltham, USA), a carbocyanine monomer nucleic acid stain with far-red fluorescence, and the slices were mounted onto superfrost slides using Vectashield mounting medium for fluorescence (Vector Laboratories, Burlingame, CA).
Thioflavin S staining
For thioflavin S staining, mouse brain sections were incubated with 0.05% of Thioflavin S (Sigma-Aldrich) in ethanol 50%, washed three times for 10 sec in 80% ethanol as previously described (Faustini et al., 2018) and then blocked for subsequent immunostaining with the antibody against Syn III. Cell nuclei were counterstained with Hoechst 33258 dye, mounted and analyzed by using a confocal microscope.
In situ Proximity Ligation Assay (PLA) studies
The in situ PLA studies on mice tissues were performed by using the Duolink assay kit (O-LINK Bioscience, Upsalla, Sweden) with a protocol adapted from the manufacturer's instruction, as h at rt and probed with the secondary antibody. Cell nuclei were then counterstained with Hoechst 33258 dye and sections were mounted on slides and analyzed by using a confocal microscope.
Confocal microscopy
Slides were observed by LSM 880 Zeiss confocal laser microscope (Carl Zeiss S.p.A., Milan, Italy) with the following laser sets: λ = 405/488/543/633 nm for quadruple TH/α-syn/Syn III/To Pro staining, 488/543/405 for triple TH/PLA/Hoechst or 543/430/405 for Syn III/Thioflavin S/Hoechst staining. The height of sections scanning was 1 μm. Images (512 × 512 pixels) were then reconstructed using ZEISS ZEN Imaging Software (Carl Zeiss S.p.A.).
Image analysis of Syn III-immunopositive area in the substantia nigra
For the quantification of Syn III immunoreactivity in the substantia nigra the acquisition parameters during confocal imaging were maintained constant for all the images acquired to perform the analysis. Brains from 3-4 mice (10 sections from each mouse, two every 150 µm) were analyzed by examining the whole area of the substantia nigra within a virtual standard grid composed of 8 fields. The total Syn III-positive area within the grid was estimated by using the FIJI software. The mean of Syn III-positive area per section was calculated by averaging the values of the 10 grids analyzed for each animal in the different experimental groups. Values were then expressed as % changes vs C57BL/6J mice.
Western blot (WB) analysis
Fresh frozen tissues from the striatum were collected from mouse brains after cervical dislocation.
Total proteins were extracted with Radioimmunoprepitation Assay (RIPA) buffer made up by 50 mM Tris-HCl pH 7.4, 150 mM NaCl, NP-40 1%, sodium deoxycholate 0.1%, sodium dodecyl sulfate (SDS) 0.1%, 1 mM NaF, 1 mM NaVO 4 plus complete protease inhibitor mixture (Roche Diagnostics, Mannheim, Germany). Protein concentration in the samples was measured by using J o u r n a l P r e -p r o o f Journal Pre-proof the Bio-Rad DCTM protein assay kit (Bio-Rad Laboratories, Milan, Italy). Equal amounts of proteins (30 µg) were run on 10% polyacrylamide gels and transferred onto polyvinylidene fluoride (PVDF) membrane. Densitometric analysis of the bands were performed by using FIJI Software and all bands were normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels as a control of equal loading of samples in the total protein extracts. For densitometry analysis of bands, each experimental condition was performed in quadruplicate and the resulting data were subjected to statistical analysis.
Real-time PCR
Total RNA was extracted from substantia nigra specimens of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice using an RNA extraction kit (RNeasy Mini Kit, Qiagen, Hilden, GE) as previously described (Faustini et al., 2018) . Two µg of RNA were retrotranscribed by using QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer's instructions. Real-time PCR was performed by using SYBR Green Master Mix (Applied Biosystems, Foster City, USA) and the following primer pairs: SYN3 for aaatcagcatcaccccaccc, SYN3 rev gccttggcctcatcttcact; GAPDH for tcaacagcaactcccactctt, GAPDH rev ccagggtttcttactccttgg.
The ViiA7 Real Time PCR system (Life Technologies, Grand Island, NY, U.S.A.) as used for 40 cycles of 95 °C for 15 s and 60 °C for 1 min. mRNA expression was normalized to GAPDH gene expression. Each experimental condition was analyzed in triplicate and the resulting data were averaged and subjected to statistical analysis.
Antibodies
A list of the primary antibodies for detection of α-syn, DAT, GAPDH, Syn III and TH and of their working concentrations in immunofluorescence, in situ PLA and WB studies is summarized in Table 1 . The secondary antibodies used for fluorescence immunohistochemistry were a goat antimouse IgG Cy3-conjugated, a goat anti-rabbit IgG Cy3-conjugated, a goat anti-rabbit Alexa488-J o u r n a l P r e -p r o o f Journal Pre-proof conjugated and a goat anti-rabbit Alexa405-conjugated (Jackson ImmunoResearch, Pennsylvania, USA). The secondary antibodies used for WB were goat anti-rabbit IgG-HRP or goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, Dallas, Texas, USA).
Open field behavioral tests
Acute locomotor activity of C57BL/6J, C57BL/6JOlaHsd, SYN120 tg and Syn III ko mice was assessed using the automated AnyMaze video tracking system (Stoelting, Wood Dale, IL) according to previously described protocols (Zaltieri et al., 2015) . The total distance travelled was recorded automatically in the open field arena (50×50 cm 2 ) and data were analyzed in 14 trials of 2.5 min each. Mice were gently placed in the arena and were allowed to explore freely for 5 min before starting the test. After 10 min of registration in basal condition, mice received an i.p. injection of cocaine (10 mg/kg, dissolved in normal saline 0.9%) (Tocris, Bristol, UK), or MPH (d-threo, 10 mg/kg, dissolved in normal saline 0.9%) (Tocris), or GBR-12935 (20 mg/kg, dissolved in normal saline 0.9%) (Tocris), whereas control mice were treated with vehicle (normal saline 0.9%). To evaluate the effect of MPH or cocaine independently of their DAT-inhibitory action, the protocol was adapted as follows. Mice were analyzed for 10 min in basal conditions, then subjected to an i.p. injection of GBR-12935 (20 mg/kg), registered for 15 min and finally subjected to an i.p. injection of either cocaine (10 mg/kg) or MPH (10 mg/kg) registering for the following 25 min. All the experiments were conducted during daylight hours. N = 6/10 animals per group were analyzed for each experimental setting including vehicle or drug treatments. streptomycin and 0.01 μM non-essential amino acids (Sigma-Aldrich). Cells were maintained at 37°C under a humidified atmosphere of 5% CO 2 and 95% O 2 .
For FRET studies, SK-N-SH cells were seeded onto poli-D-lysine-coated 13 mm glass coverslips in 24-well plates (15000 cells per coverslip) and were maintained in differentiation medium for ten days by daily adding 10 μM retinoic acid to the complete medium. At day 7, cells were transiently After identifying double positive cells three-to-six regions of interest (ROI) were analyzed for 4 series. Two images of basal condition (Pre-bleaching) were acquired before bleaching the RFP acceptor fluorophore with laser 543 set at 65% power. Then, other two images were acquired after the bleaching (Post-bleaching).
The FRET efficiency (intended as the GFP recovery after RFP photobleaching) was measured by using Zen black software (Carl Zeiss). The average intensity of the background (outside the cell) was subtracted from the average intensity of the ROI and all the FRET values resulting from the different ROI were used for statistical analysis. The frame number 4 of the nuclear magnetic resonance (NMR) structure of α-syn (2KKW) was used to pursue docking studies by means of Glide (https://www.schrodinger.com). The protein was prepared with the protein preparation tool of Maestro (https://www.schrodinger.com) and the docking grid was centered so as to cover the whole region where the N-terminal and C-terminal domains are in close proximity. MPH was prepared with the atom builder tool of Maestro. Each docking run was carried out using the standard precision (SP) method and the Van der Waals scaling factor of nonpolar atoms was set to 0.8. The binding mode having the highest score was selected after visual inspection. The (1-120) α-syn MPH complex was prepared starting from the generated model of fl α-syn in complex with MPH. The fl α-syn was then truncated at the 120 th residue and the complex thus obtained was submitted to a stepwise refinement protocol, where the complex was refined by applying harmonic constraints that were progressively reduced until no constraints were applied.
Molecular Modeling of MPH interaction with either fl or C-terminally truncated α-syn

Statistical analysis
Statistical differences in the protein levels detected by WB or estimated by immunofluorescence and in mRNA expression between groups (C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice)
were assessed by using one-way ANOVA followed by Bonferroni's multiple comparisons test (n = 6 animals for each group for WB and immunofluorescence analysis and n = 3 animals for each group for qPCR analysis). Statistical differences between the total distance travelled in the open field test by the different experimental groups (C57BL/6J, C57BL/6JOlaHsd and SYN120 tg or Syn III ko and wt mice or SYN120 tg mice injected with shSyn III and scramble) were assessed by using two-way ANOVA followed by Bonferroni's multiple comparisons test (n = 6-12 animals for each group). Differences in the mean FRET efficiencies of SK-N-SH cells were assessed by using one-way ANOVA + Newman-Keuls post comparison test (n = 15-20 cells for each experimental condition). Differences in the Syn III immunopositive area in the substantia nigra between SYN120 tg mice injected with scramble shRNA or shRNA for Syn III gene silencing were analyzed by J o u r n a l P r e -p r o o f
Results
Synapsin III deposition and interaction with α-syn in the substantia nigra.
We recently showed that 12-month-old C57BL/6JOlaHsd α-syn null mice display striatal redistribution and accumulation of Syn III when compared to C57BL/6J littermate controls (Zaltieri et al., 2015) . The Syn III alterations are even more pronounced in the striatum of 12-month-old SYN120 tg mice overexpressing C-terminally truncated α-syn on the C57BL/6JOlaHsd background (Zaltieri et al., 2015) , which at this age exhibit a marked deposition of fibrillary aggregated α-syn as well as SNAREs and DAT redistribution accompanied by DA release failure, as we previously showed (Bellucci et al., 2011; Garcia-Reitbock et al., 2010; Tofaris et al., 2006) . Here, we investigated Syn III immunolabeling and co-localization with Thioflavin S-positive fibrillary aggregates in the substantia nigra TH-positive neurons of 12-month-old SYN120 tg vs. C57BL/6J or C57BL/6JOlaHsd mice in order to evaluate the presence of Syn III within α-syn aggregates in this brain area. In line with our previous findings on striatal sections (Zaltieri et al., 2015) , confocal analysis showed accumulation of Syn III in substantia nigra TH-positive neurons of C57BL/6JOlaHsd α-syn null and even more in those of SYN120 tg mice, with respect of C57BL/6J littermates ( Fig. 1A-C ; Supplementary Fig. 1A ). While in the nigral TH-positive cells of α-syn null mice Syn III immunoreactivity displayed a dot-like sparse distribution ( Fig. 1B, arrows) , in those of SYN120 tg mice it exhibited a more condensed dot-like or mealy-granular appearance (Fig. 1C arrows) and showed a marked co-localization with α-syn ( Fig. 1C merge) . In C57BL/6J mice, Syn III staining was poor ( Fig. 1A) .
We then assessed α-syn and Syn III interaction in the substantia nigra TH-positive neurons by in situ PLA ( Fig. 1D-F) , which allows to visualize protein-protein interactions in intact tissues (Bellucci et al., 2014; Faustini et al., 2018) . We found that 12-month-old C57BL/6J mice exhibited a basal α-syn/Syn III PLA signal supportive of the occurrence of Syn III/α-syn interaction (Fig.   1D ). The PLA signal was increased in the nigral TH-positive cells of SYN120 tg mice ( Fig. 1F ), suggesting an augmented interaction between C-terminally truncated (1-120) α-syn and Syn III. The J o u r n a l P r e -p r o o f absence of PLA staining in the substantia nigra of C57BL/6JOlaHsd mice ( Fig. 1E ) confirmed the specificity of the assay.
Fig. 1 1.5-column fitting image
As stated above, 12-month-old SYN120 tg mice exhibit α-syn fibrillary aggregation in the substantia nigra (Tofaris et al., 2006) . Here, we observed a marked co-localization between Syn III immunolabeling and Thioflavin S staining in both the substatina nigra and striatum that supports the presence of Syn III within the fibrillary α-syn aggregates in the nigrostriatal neurons of these mice (Fig. 2 ).
Fig. 2 2-column fitting image
Age-related changes in Syn III and DAT levels in the striatum of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice
The age-dependent changes in α-syn, DAT and Syn III levels in the striatum of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice were assessed at 3, 8, 12 and 16 months of age ( Fig. 3 ) by WB.
In line with our previous findings (Tofaris et al., 2006) , we observed that the expression of Cterminally truncated α-syn in SYN120 tg mice was lower than fl wt α-syn in the C57BL/6J littermate controls ( Fig. 3) . Indeed, the expression of (1-120) α-syn in SYN120 tg mice is under the control of the rat TH promoter and is thus restricted to striatal dopaminergic terminals. The C57BL/6JOlaHsd mice did not show α-syn ( Fig. 3) .
At 3 months of age, DAT levels were decreased in C57BL/6JOlaHsd mice when compared to both C57BL/6J and SYN120 tg littermates. However, this difference was abated in 8-month-old animals ( Fig. 3) . We then found that in SYN120 tg mice, DAT levels were significantly augmented at 12 and 16 months of age, when compared to control C57BL/6JOlaHsd littermates. This augment in DAT levels cannot be indicative of increased dopaminergic projections in the striatum, as supported by the significant decrease of basal and depolarization-dependent DA release and of its main J o u r n a l P r e -p r o o f metabolites 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) that we previously described in the SYN120 tg mice from 12 months of age (Garcia-Reitbock et al., 2010) .
It can rather be ascribed to other compensatory mechanisms regulating the DAT in response to DA release failure or α-syn aggregation. Consistently, in line with the results we report here and our previous findings (Bellucci et al., 2011) , a recent study showed the occurrence of DAT upregulation and α-syn/DAT complexes formation as early pathological events in non-human primates who received putaminal injection of α-syn preformed fibrils and exhibiting loss of nigrostriatal neurons (Chu et al., 2019) .
We then observed that, at 3, 8 and 12 months of age, the absence of α-syn induced a statistically significant increase of Syn III in C57BL/6JOlaHsd mice when compared to the C57BL/6J littermates. At 3 and 8 months of age, the levels of Syn III were reduced in SYN120 tg mice when compared to C57BL/6JOlaHsd littermates, suggesting that the presence of α-syn, even if in the truncated form, may attenuate the massive increase of Syn III. This notwithstanding, SYN120 tg mice exhibited a progressive increase of Syn III levels which was comparable to that of C57BL/6JOlaHsd animals at later time points ( Fig. 3 ). Since aggregation of (1-120) α-syn has been detected from 6 months of age in the brains of SYN120 tg mice (Tofaris et al., 2006) , it is feasible that the early down-regulation of Syn III levels in the striatum may be ascribed to the enhanced production of soluble C-terminally truncated α-syn which might later lose this action when fibrillation begins.
Fig. 3. 2-column fitting image
To further corroborate whether the expression of C-terminally truncated α-syn on the C57BL/6JOlaHsd background could quench Syn III expression similarly to wt protein in C57BL/6J mice, we assessed Syn III mRNA levels by real-time quantitative PCR at 3 and 12 months of age ( Supplementary Fig. 1B) . At 3 months of age, the expression of Syn III mRNA was significantly increased in C57BL/6JOlaHsd mice when compared to wt mice. In parallel, Syn III expression in the SYN120 tg mice was decreased vs C57BL/6JOlaHsd and increased vs C57BL/6J littermates, J o u r n a l P r e -p r o o f Journal Pre-proof but these changes did not result statistically significant. At 12 months of age, the differences in relative Syn III mRNA expression observed between C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice mirrored the changes in protein levels detected by WB ( Supplementary Fig. 1B ).
Although the decrease of Syn III mRNA observed in SYN120 tg mice at 3 months of age did not exactly retrace the reduction of the protein, as detected by WB, it is known that mRNA amount will not always reflect the level of the encoded protein. Indeed, the amount of mRNA within a cell is determined by the ratio of its synthesis and degradation rates, which are finely regulated processes (Mattick, 2004) . Moreover, WB analysis was conducted on striatal samples, while for qPCR experiments we used substantia nigra samples, as synapsins are synthesized in neuronal soma and then transferred to terminals through axonal transport (Tang et al., 2013) .
Alpha-synuclein and Syn III interplay influences the locomotor response to MPH
We then wanted to expand our previous studies on the effect of cocaine administration in 12-monthold wt and C57BL/6JOlaHsd mice (Zaltieri et al., 2015) in order to evaluate the effect of different MRIs in these mouse lines and SYN120 tg animals at the time points used for the investigation of striatal proteins levels. In particular, we analyzed the acute locomotor response to the i.p. administration of cocaine (10 mg/kg), MPH (10 mg/kg, d-threo), GBR-12935 (20 mg/kg) or vehicle in C57BL/6J, C56BL/6JOlaHsd and SYN120 tg mice by using the open field behavioural paradigm (Zaltieri et al., 2015) . We registered the distance travelled by mice in 2.5 min intervals for 10 min in basal condition and for 25 min after the i.p. administration of the drugs.
At 3 months of age, C57BL/6J mice exhibited a significant improvement of locomotion after cocaine administration, while C57BL/6JOlaHsd mice did not respond (Fig. 4A ), in agreement with the fact that they display both reduced DAT levels and a marked increase of Syn III. Interestingly, 3-month-old SYN120 tg mice showed a significantly higher locomotor activity 5, 7.5 and 10 min after cocaine administration when compared to C57BL/6JOlaHsd littermates. This suggests that, in J o u r n a l P r e -p r o o f Journal Pre-proof spite of the C57BL/6JOlaHsd background, the expression of C-terminally truncated α-syn in THpositive neurons of 3-month-old SYN120 tg mice sustained a mild response to cocaine.
In line with the WB data, supporting a rebalance of DAT levels in the three mouse lines at 8 months of age, we found that C57BL/6JOlaHsd mice exhibited a statistically significant increase in the distance travelled in the interval between 7.5 and 17.5 min after cocaine administration, when compared to SYN120 tg mice, which lost the mild locomotor response observed at 3 months of age.
The increase in motility observed in 8-month-old C57BL/6JOlaHsd mice following cocaine administration, that was not detected in the animals at 3 months of age, may be ascribed to striatal DAT increase in conjunction with elevated Syn III levels, as these proteins can additively contribute to raise the response to this drug. Indeed, Kile and co-authors showed that only single Syn III ko mice exhibit enhanced striatal dopaminergic functions but in parallel that cocaine-stimulated DA release is reduced in synapsin I/II/III triple ko animals (Kile et al., 2010) . This supports that, although Syn III is the only synapsin exerting a negative regulatory control of DA release in the striatum, cocaine effect is reduced in the absence of Syn III but can instead be enhanced by the increase of this protein. This outcome may have worked in concert with a more marked cocaineinduced DA re-uptake inhibition related to DAT increase to uplift the locomotor response of the αsyn null mice at 8 months of age.
In line with this hypothesis and our previous observations (Zaltieri et al., 2015) , when we studied the locomotor response to cocaine administration at 12 months of age, we found that C57BL/6JOlaHsd mice exhibited a delayed increase in their peak of motility, which however was significantly higher vs that observed in C57BL/6J wt mice, and rapidly dropped in the interval between 15 and 17.5 min after cocaine administration. This supports that, with the prolonged absence of α-syn, the kinetic of Syn III-dependent DA release may differ from the standard DATmediated effect. Again, 12-month-old SYN120 tg mice did not respond to cocaine administration, supporting that the significant increase of striatal DAT levels is not sufficient to recover the response to cocaine. This may be explained by the fact that these mice show a marked reduction of J o u r n a l P r e -p r o o f Journal Pre-proof striatal DA release as well as alterations in the distribution of Syn III, DAT and SNARE proteins (Bellucci et al., 2011; Garcia-Reitbock et al., 2010; Zaltieri et al., 2015) .
At 16 months of age, C57BL/6JOlaHsd mice lost their ability to respond to the acute cocaine treatment, suggesting that they lost their dopaminergic striatal functions along aging. Indeed, nigrostriatal neurons from α-syn ko mice may exhibit a lower vulnerability threshold during aging.
In particular, they show reduction of TH-positive fibers in the striatum and decrease of striatal levels of TH and DAT accompanied by decrease of DA and its metabolites, without any change in the overall number of TH-positive neurons in the substantia nigra (Al-Wandi et al., 2010; Connor-Robson et al., 2016) . Finally, we found that the locomotor response of 16-month-old C57BL/6J and SYN120 tg mice was almost comparable to that observed at 12 months of age.
We then studied the motor response of mice to MPH administration (Fig. 4B) . At 3 and 8 months of age, SYN120 tg, C57BL/6JOlaHsd and C57BL/6J mice similarly responded to MPH administration in spite of the differences in DAT and Syn III levels (Fig. 4B) . Surprisingly, at 12 months of age, SYN120 tg mice manifested a paradoxical and statistically significant motility increase when compared to C57BL/6J and C57BL/6JOlaHsd littermates, which showed comparable behaviors.
The hyper-response to MPH administration of SYN120 tg mice persisted at 16 months of age, when also C57BL/6J mice exhibited a mild peak in the locomotor response in the first ten minutes following MPH administration, while C57BL/6JOlaHsd mice showed the same kind of motility observed at younger ages. These findings support that the locomotor response to MPH administration is enhanced in the presence of C-terminally truncated α-syn aggregates, when these are occurring in parallel to the increase of Syn III and DAT, in spite of the co-aggregation of these proteins with α-syn.
In order to estimate the exact contribution of DAT inhibition to the locomotor response of mice along aging, we also evaluated their motility following GBR-12935 administration ( Supplementary   Fig. 2A ). In line with the decreased DAT levels observed in C57BL/6JOlaHsd and with our previous observation (Bellucci et al., 2011) , we found a decreased activity of C57BL/6JOlaHsd and J o u r n a l P r e -p r o o f Journal Pre-proof SYN120 tg mice when compared to C57BL/6J control mice at all the time point analyzed. This suggests that the formation of α-syn/DAT inclusions induces an impairment of DAT trafficking in SYN120 tg mice. Indeed, in line with evidence supporting a direct interaction between the central region of α-syn (aa 61-95) and DAT C-terminus (Lee et al., 2001), we and others have shown that α-syn affects DAT surface expression (Adamczyk et al., 2006; Bellucci et al., 2008; Chu et al., 2019; Fountaine and Wade-Martins, 2007; Wersinger and Sidhu, 2003; Wersinger and Sidhu, 2005) . Among the synucleins, α-syn results the most efficient in negatively regulating physiological DAT transport to the plasma membrane (Oaks and Sidhu, 2013) . Therefore, although we observed increased levels of DAT in SYN120 tg mice vs α-syn null littermates, the lower response to GBR-12935 that they exhibited could result from an α-syn-induced decrease of DAT membrane transport efficiency occurring in response to (1-120) α-syn expression on the C57BL/6JOlaHsd α-syn null background, that may have been worsened by the progressive aggregate formation.
Fig. 4 1.5-column fitting image
During all the behavioural tests, parallel groups of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice were injected with vehicle (normal saline 0.9%) and analyzed. These mice showed a locomotor response that had similar basal conditions, supporting that the vehicle injection did not influence their motility ( Supplementary Fig. 2B ).
To further clarify the relevance of DAT blockade in cocaine-or MPH-induced locomotor activity, we analyzed the motility of 12-month-old mice after GBR-12935 administration, followed by either cocaine or MPH treatment (Fig. 5A,B) . GBR-12935 pre-administration was used to induce DAT blockade, in order to ensure that the locomotor response observed after cocaine or MPH was independent of DAT inhibition. We found that SYN120 tg mice neither responded to GBR-12935, nor to the subsequent cocaine administration. C57BL/6J and C57BL/6JOlaHsd mice positively responded to GBR-12935 and showed a fast peak in motor activity 2.5 min after cocaine treatment, followed by different time-dependent attenuation (Fig. 5A ). This phenomenon may be the result of a compensatory decrease of DA release deriving from an overstimulation of striatal D2 J o u r n a l P r e -p r o o f Journal Pre-proof autoreceptors in response to the marked increase of extra-synaptic DA resulting from the additive effect of GBR-12935 and cocaine. The analysis of the total distance travelled in the three different experimental tranches (basal condition, GBR-12935 single administration, cocaine administration following GBR-12935) confirmed the above results (Fig. 5B) .
When we analyzed the locomotor response to MPH administration after GBR-12935 ( Fig. 5A ), we found that SYN120 tg mice still exhibited an enhanced locomotion starting 5 min after MPH treatment. These findings suggest that the MPH-mediated stimulation of locomotor activity in SYN120 tg mice does not depend on DAT inhibition, which was achieved by GBR-12935-operated blockade, but rather on the pathological α-syn/Syn III interplay. In support of this, the motor response of C57BL/6J control mice resulted comparable to that observed after GBR-12935 plus cocaine injection, and C57BL/6JOlaHsd animals only showed a mild but not significant motility increase 10 min after MPH administration. The analysis of the total distance travelled in the different experimental tranches confirmed these results (Fig. 5B) .
To evaluate the relevance of Syn III in the motor response to MPH, cocaine or vehicle administration, we performed the open field tests in 12-month-old Syn III ko and C57BL/6J mice ( Fig. 5C, Supplementary Fig. 3A ). We found that Syn III ko mice did not exhibit any improvements of motility after the administration of these drugs. This observation collimates with findings indicating that the ability of cocaine to enhance DA release is reduced in the absence of Syn III (Kile et al., 2010) .
Finally, we probed whether the enhanced locomotor response to MPH administration observed in aged SYN120 tg mice could effectively be mediated by a cooperative action of α-syn and Syn III.
To this purpose, 12-month-old SYN120 tg mice were subjected to AAV-mediated Syn III gene silencing and the locomotor response of these mice after an acute MPH challenge was evaluated at 16 months of age (Fig. 5D ). Quantification of Syn III immunolabeling in the substantia nigra of mice showed a statistically significant reduction of Syn III-positive area in the animals which were injected with the AAV transducing the Syn III shRNA ( Supplementary Fig 3B,C) . Remarkably, the J o u r n a l P r e -p r o o f Journal Pre-proof animals subjected to Syn III gene silencing lost the capability to respond to MPH administration, while those injected with the AAV transducing scramble shRNA sequences could still respond to the drug. This observation confirms that Syn III is implicated in MPH action. In light of our previous findings showing that 12 and 16-month-old C57BL/6JOlaHsd mice, that express elevated Syn III levels in the absence of α-syn, did not exhibit the paradoxical increase in locomotion observed in SYN120 tg mice, the latter results further suggest that MPH-mediated stimulation of locomotor activity may be co-orchestrated by α-syn and Syn III pathological cooperation.
Fig. 5 2-column fitting image
MPH stimulates the interaction between Syn III and fl or (1-120) human α-syn
To better understand how cocaine, MPH (d-threo) or GBR-12935 could affect the interplay between α-syn and Syn III, we evaluated whether an acute 15 min treatment with these compounds could affect the interaction between either fl or (1-120) α-syn and Syn III by using acceptor photobleaching FRET (Fig. 6A) , in a cell culture system reproducing α-syn/Syn III inclusion formation. Acceptor photobleaching FRET microscopy allows an accurate evaluation of proteinprotein interaction through the measurement of FRET efficiency. This parameter is indicative of the increase of donor fluorescence after complete photobleaching of the acceptor fluorescence, within a FRET pair of fluorophores (where the emission wavelength of a donor falls within the excitation wavelength of an acceptor). Since FRET efficiency is detectable only when the two fluorophores are sufficiently close to ensure that their linked proteins are interacting, the molecular proximity of these latter results strictly dependent on this parameter (Bajar et al., 2016; Ishikawa-Ankerhold et We also observed that Syn III ko mice did not respond to cocaine or MPH administration, although they did not display differences in DAT striatal levels (Faustini et al., 2018) . This is fully in line with previous findings showing that cocaine reduces striatal DA release in these mice (Kile et al., 2010) and sustains that cocaine and MPH effect is dependent on the presence of Syn III. However, the Syn III-mediated locomotor activity can be alternatively influenced in the absence or in the presence of different α-syn conformational variants.
The observation that aged SYN120 tg mice, which show elevated α-syn aggregation, acquire the ability to respond to MPH treatment, is reminiscent of the fact that MPH efficiently counteracts freezing of gait and hypokinesia in advanced PD patients (Delval et al., 2015; Devos et al., 2007; Moreau et al., 2012; Nikolai Gil D. Reyes, 2018; Pollak et al., 2007) . This effect does not rely on the increase in attentional performance (Delval et al., 2015) and, although it can enhance L-DOPA efficacy (Camicioli et al., 2001) , it does not necessarily require exogenous L-DOPA (Pollak et al., 2007) . It has been also observed that MPH can redistribute DA vesicle pools (Sandoval et al., 2003) . In light of our results, we may speculate that the MPH-associated trafficking of synaptic vesicles in dopaminergic neurons could be mediated by α-syn/Syn III interplay, as these proteins can both control synaptic vesicle pools (Burre, 2015; Cesca et al., 2010) . MPH has demonstrated therapeutic efficacy in Attention Deficits and Hyperactivity Disorder (ADHD) (Huss et al., 2017) , a neurodevelopmental disorder whose onset has been found to positively correlate with the 631 C>G Syn III polymorphism (Kenar et al., 2013) , which can contribute to the efficacy of MPH itself (Basay et al., 2016) . Our group has also shown that Syn III is a crucial mediator of early neuronal development, migration and orientation (Perlini et al., 2015; Piccini et al., 2015) , findings that further support that Syn III polymorphisms may significantly contribute to the neurodevelopmental change underlying ADHD. Interestingly, ADHD patients manifest a psychostimulant-medication independent predisposition to develop disorders of the basal ganglia, including PD and LB dementia (Curtin et al., 2018; Golimstok et al., 2011) . Moreover, a recent study supports that the rs356219 genotype in SNCA may affect α-syn function and contribute to the etiology of ADHD (Gerlach et Cocaine and MPH have been found to bind α-syn. In particular, the former binds the N-terminus of α-syn and prompts the formation of more compact protein conformation, while the latter promotes loop-like α-syn folding through a contemporaneous strong N-terminal and weak C-terminal interaction (Kakish et al., 2015) . Cocaine and MPH can increase or decrease DA neurotransmission by blocking reuptake and reducing exocytotic release, respectively (Federici et al., 2014) .
Moreover, while cocaine can stimulate Syn III-dependent DA release independently of Calcium concentrations (Kile et al., 2010) , MPH can influence α-syn-mediated DA overflow and presynaptic compartmentalization, but its effect on DA reuptake is independent of α-syn (Chadchankar et al., 2012) . Our results support that cocaine action is not significantly influenced by the pathological αsyn/Syn III interplay, which however actively contributes to the effect of MPH.
It has been shown that, in pathological conditions, α-syn can form metastable cytotoxic oligomers which give raise to the formation of the insoluble fibrils composing LB (Longhena et al., 2019) . In such cases, following a basic aggregation mechanism (Chiti and Dobson, 2006) , it has been hypothesized that the central hydrophobic core (residue 61-95) adopts in-register β-sheets conformations, promoting fibril formation (Tuttle et al., 2016) . Interestingly, by concurrently binding both the N-and C-termini of α-syn (but not the central region), MPH interacts with α-syn in such a way that stabilizes the protein in a conformation less prone to aggregate and can thus be considered neuroprotective (Kakish et al., 2015) . The NMR structure of α-syn previously reported in Rao et al., (2010) showed the presence of 2KKW sequence that can be identified as a potential source of interesting α-syn conformations suitable for such task. Indeed, by combining NMR and spin labelling/electron paramagnetic resonance (EPR), Rao and co-workers reported an ensemble of 34 α-syn structures exhibiting partially folded conformations upon micelle binding (Rao et al., 2010) . In one of these conformations, by showing an N-terminal domain folded into a classical αhelix secondary element in close proximity to the unfolded C-terminal domain and the central core J o u r n a l P r e -p r o o f Journal Pre-proof adopting α-helix structure, α-syn results less prone to generate fibrillary aggregates (Kakish et al., 2015; Rao et al., 2010) . In the attempt to confirm the heuristic model for α-syn in complex with MPH by Kakish and co-authors (Kakish et al., 2015) , we identified one α-syn conformation able to interact with MPH within those reported by Rao and co-authors (Fig. 7A) . Docking studies of MPH in its D-threo configuration and this particular fl α-syn conformation confirmed that MPH interacts with the α-helix secondary element-folded N-terminal domain of α-syn through the positively charged Lys10 residue (Fig. 7B) . Concomitantly, it plunges the positively charged nitrogen atom into a region of the proximal unfolded C-terminal domain enriched in negatively charged residues and defined by Asp119 and Asp121 residues, while the central core is stabilized into an α-helix ( Fig. 7B) . This in silico model sounds also in agreement with above described data showing that MPH is effective on SYN120 tg mice, since Asp119 is conserved in the (1-120) α-syn construct ( Fig. 7C) , thus supporting the reliability of the generated complexes. These observations provide putative structural details underlying the protective effect of MPH on αsyn/Syn III neuropathology. In particular, they support that MPH stabilizes α-syn into a conformation not suitable to fibrillary aggregation, which rather displays improved capacity to establish a functional interaction with Syn III, that in turn results in the observed Syn III-dependent locomotor activity. Interestingly, this conformation is stabilized by micelle binding (Rao et al., 2010) , suggesting that lipids, or more probably synaptic vesicle proximity, may promote its formation. Notably, α-syn aggregation can cluster and disorganize synaptic vesicles (Faustini et al., 2018; Wang et al., 2014) . This evidence, when coupled to recent findings showing that LB are constituted by a lipid crowded environment which contains dispersed protein filaments (Shahmoradian et al., 2019) , supports that synaptic vesicles and organelles may be entrapped by αsyn/Syn III fibrillary aggregates during LB formation. It may thus be feasible that along with α-syn fibril deposition, different α-syn conformational variants with diverse lipid binding affinity and function may be easily generated. The Syn III-dependent MPH effect, likely mediated by an N-J o u r n a l P r e -p r o o f Journal Pre-proof terminal and central region α-helical α-syn conformation resulting from lipid interaction, occurs only in aged SYN120 tg mice and seems to be fully in line with a progressive lipid crowding model of LB. This notwithstanding, due to the dynamic nature of α-syn, we cannot firmly exclude that MPH could also stabilize different conformation/s with respect of that analyzed in this study. It may be also feasible that specific post-translational modifications of α-syn may be relevant for MPH action in SYN120 tg mice.
Conclusions
Collectively, our results support that Syn III and α-syn are both involved in mediating the motor response to cocaine and MPH (Fig. 8 ). Furthermore, they unveil that MPH effect can be positively fostered in the presence of α-syn and Syn III co-aggregates, in particular when the levels of these proteins are markedly elevated. Finally, we also found that MPH stimulates α-syn/Syn III interaction in cells showing α-syn/Syn III co-aggregates and provided a model supporting that this drug stabilizes α-syn in a conformation with low aggregation propensity. When seen in the light of clinical studies supporting the efficacy of MPH in counteracting freezing of gait in advanced PD, our findings hint that α-syn/Syn III pathological coaction could be the mediator of this effect. This supports that drugs modulating α-syn/Syn III interplay may constitute valid therapeutic options for treating this neurodegenerative disorder. Not least, they hold significant implications also in the field of ADHD. Table 1 : List of the primary antibodies used for the study including their characteristics and working dilutions. Cell nuclei were counterstained with HOECHST. Scale bar 10 μm.
Fig. 2
Syn III immunolabeling coupled with Thioflavin S staining in the substantia nigra and striatum of 12-month-old C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice.
A. Marked accumulation of the Thioflavin S signal, indicative of protein fibrillation, in colocalization with Syn III immunopositive labeling in the substantia nigra of SYN120 tg mice. B.
Marked Syn III and Thioflavin S co-localizing signals were also observed in the striatum of J o u r n a l P r e -p r o o f SYN120 tg mice. Please note that asterisks are located nearby non-specific lipofuscin signal. Scale bar A: 100 μm, B: 10 µm.
Fig. 3
Analysis of the levels of α-syn, DAT and Syn III in the striatum of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice at 3, 8, 12, 16 months of age.
The expression of (1-120) α-syn in SYN120 tg mice resulted lower than that of endogenous wt αsyn in C57BL/6J littermate controls at all the time point analyzed (### P < 0.001, One-way ANOVA + Bonferroni's post-comparison test). C57BL/6J exhibited a statistically significant difference in α-syn immunopositivity when compared to C57BL/6JOlaHsd littermates which did not exhibit α-syn immunopositivity (*** P < 0.001, One-way ANOVA + Bonferroni's postcomparison test). Three-month-old C57BL/6JOlaHsd mice displayed decreased DAT levels when compared to both C57BL/6J (*** -52.66 %, P < 0.001, One-way ANOVA + Bonferroni's postcomparison test) and SYN120 tg mice (°°° -55.78 %, P < 0.001, One-way ANOVA + Bonferroni's post-comparison test). These differences were lost at 8 months of age. The levels of DAT resulted significantly increased in 12-and 16-month-old SYN120 tg mice when compared to C57BL/6JOlaHsd littermates (°°° + 53.73 %, P < 0.001 and ° + 79.04 %, P < 0.05, One-way ANOVA + Bonferroni's post-comparison test). A significant increase of Syn III levels was observed in C57BL/6JOlaHsd mice when compared to C57BL/6J littermates at 3, 8 and 12 months of age (* + 87.65%, P < 0.05 at 3 months and *** + 82.86 % at 8 months, *** + 68.38% at 12 months, P < 0.001, One-way ANOVA + Bonferroni's post-comparison test). At 3 and 8 months of age, the levels of Syn III in SYN120 tg mice were comparable to those of C57BL/6J littermates, but resulted significantly reduced when compared to C57BL/6JOlaHsd mice (° -103.5 %, P < 0.05 at 3 months and °° -54.54 %, P < 0.01 at 8 months, One-way ANOVA + Bonferroni's post-comparison test). This notwithstanding, at 12 and 16 months SYN120 tg mice showed an age-related increase in Syn III levels, which returned comparable to those of C57BL/6JOlaHsd mice but were significantly J o u r n a l P r e -p r o o f augmented when compared to C57BL/6J littermates (### + 106.3%, P < 0.001 at 12 months and # + 88.57%, P<0.05 at 16 months, One-way ANOVA + Bonferroni's post-comparison test).
Fig. 4
Effect of cocaine or MPH administration on the locomotor activity of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice at 3, 8, 12 and 16 months of age.
A. Cocaine differentially affected the locomotor response of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice at all the time point analyzed (3 months: interaction: F 26,180 = 3.139: 8 months:
interaction: F 26,210 = 2.652, P < 0.0001; 12 months: interaction: F 65,286 = 7.120, P < 0.0001; 16 months: interaction: F 26,340 = 2.538 P < 0.001). At 3 and 16 months of age C57BL/6J mice showed an enhanced locomotor response to cocaine vs C57BL/6JOlaHsd (*** P < 0.001, ** P < 0.01, * P < 0.05) or SYN120 tg littermates (# P<0.05, ## P<0.01, ### P<0.001). At 3 months of age these latter showed a mild statistically significant increase in the locomotor response to cocaine vs C57BL/6JOlaHsd mice (° P<0.05, °° P<0.01). At 8 months of age, the locomotor response of C57BL/6JOlaHsd mice to cocaine administration was comparable to that observed in C57BL/6J animals, but out matched that of SYN120 tg mice (° P<0.05, °° P<0.01). Twelve-month-old C57BL/6JOlaHsd mice exhibited a significant increase in the locomotor response to cocaine vs wt littermates (*** P < 0.001, ** P < 0.01, * P < 0.05) and SYN120 tg mice (° P<0.05, °° P<0.01, °°° P<0.001). Finally, at 16 months of age only C57BL/6J mice were able to display a locomotor response to cocaine administration and exhibited significant differences vs both C57BL/6JOlaHsd (*** P < 0.001, * P < 0.05) and SYN120 tg mice (### P<0.001), which showed comparable feedbacks.
B. MPH differentially affected the locomotor response of C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice at all the time point analyzed (3 months: interaction: F 26,210 = 1.553, P < 0.05; 8 months: interaction: F 26,82 = 0.2541; 12 months: interaction: F 26,210 = 3.901, P < 0.0001; 16 months: interaction: F 26,405 = 2.299 P < 0.001). At 3 months of age C57BL/6J mice exhibited a mild increase J o u r n a l P r e -p r o o f Journal Pre-proof in MPH-stimulated motility vs C57BL/6JOlaHsd (* P < 0.05) and SYN120 tg mice (# P < 0.05, ## P < 0.01), which behaved similarly. At 8 months of age, the three mouse lines showed similar responses. At 12 and 16 months of age SYN120 tg mice exhibited a statistically significant improvement in the locomotor response to MPH administration vs C57BL/6J (# P < 0.05, ## P < 0.01 and ### P < 0.001) and C57BL/6JOlaHsd littermates (°° P < 0.01 and °°° P < 0.001). Sixteenmonth-old C57BL/6J mice showed a brief statistically significant increase in the locomotor response at 5 and 7.5 minutes from MPH injection when compared to C57BL/6JOlaHsd mice (** P < 0.01 and *** P < 0.001).
Fig. 5
Cocaine-and MPH-induced locomotor responses after GBR-12935 pretreatment in 12-monthold C57BL/6J, C57BL/6JOlaHsd and SYN120 tg mice.
A. Two-way ANOVA showed that the three mouse lines exhibited a differential locomotor response to the sequential administration of either GBR-12935 + cocaine (interaction: F38,321 = 4.211, P < 0.0001) or GBR-12935 + MPH (interaction: F38,643 = 9.7, P < 0.0001). After GBR-12935 administration we detected a decreased locomotor activity in C57BL/6JOlaHsd (* P < 0.05, ** P < 0.01, *** P < 0.001) and SYN120 tg mice (# P < 0.05, ## P < 0.01, ### P < 0.001) vs to C57BL/6J littermates. After cocaine stimulation C57BL/6J showed a peak of motility that was significantly higher than that observed in SYN120 tg (### P < 0.001) and C57BL/6JOlaHsd mice (***P < 0.001), but then rapidly dropped to basal levels. After cocaine administration the motility of C57BL/6JOlaHsd resulted significantly augmented when compared to SYN120 tg (°°° P < 0.001) and C57BL/6J mice (* P < 0.05 and *** P < 0.001). In C57BL/6J mice MPH induced a quick motility increase vs C57BL/6JOlaHsd (*** P < 0.001) and SYN120 tg mice (### P < 0.001), which rapidly dropped to basal values. MPH significantly enhanced the motility of SYN120 tg mice vs C57BL/6J (### P<0.001) and C57BL/6JOlaHsd mice (°° P < 0.01 and °°° P < 0.001). 
Fig. 7
In-silico simulation of MPH and fl or (1-120) α-syn interaction A. Cartoon representation of α-syn fl (1-140) and α-syn-Δ120-140 (1-120). The N-Terminal domain (residues 1-60), the central hydrophobic region (residues 61-95) and the C-terminal domain (residues 96-140/120) are colored in blue, yellow and red, respectively. Both 3-D (green sticks) and 2-D structure of D-threo-methylphenidate (D-threo-MPH) are depicted.
B. MPH (as green, red and blues spheres) in complex with fl α-syn (as surface color coded accordingly to residue charges, where red indicates negatively charged residues, blue positively charged residues and white hydrophobic residues). The Lys110 and Asp119-120 are highlighted in black circles. C. MPH (as green, red and blues spheres) in complex with α-syn-Δ120-140 (as surface color coded accordingly to residue charges, where red indicates negatively charged residues, blue positively charged residues and white hydrophobic residues). 
